Under construction – not a live service
Sign in
Taking people in PolandNo phase

H-34 DELTA Revision Cup

Key facts

Where
Otwock, PolandSee the site

Where in Poland

  • Samodzielny Publiczny Szpital Kliniczny im. Prof. Adama Grucy CMKPOtwock, PolandContact: Jerzy BialeckiTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Limacorporate S.p.a
Trial code
NCT06359301
Record updated
22 January 2026
Original description
THis study is aimed to provide a clinical and radiographic evaluation of 49 suitable subjects who underwent a total hip arthroplasty with DELTA Revision acetabular cup.Read full original descriptionShow less

An Open Label, Observational, Prospective, Longitudinal Cohort Study to Evaluate Safety, Clinical and Radiographic Outcomes of Total Hip Arthroplasty With DELTA Revision Cup

THis study is aimed to provide a clinical and radiographic evaluation of 49 suitable subjects who underwent a total hip arthroplasty with DELTA Revision acetabular cup.

Inclusion: male or female in whom a decision has already been made to perform a total hip arthroplasty with DELTA Revision acetabular cup as per indication for use. The decision to implant DELTA revision acetabular cup must be taken prior to, and independently from the decision to enroll the patient. This decision should be made in accorsance with routine clinical practice at the study site concerned; Age ≥ 18 years old; All patients mist give written informed consent approved by the study site's Institutinal Review Board (IRB)/Ethical Committee (EC); Patient is able to comply with the protocol.

Exclusion: Adult patients with any DELTA Revision acetabular cup contraindication for use as reported in the current local instruction for use; For female patiens, current pregnancy and/or lactation or planning a pregnancy.

ClinicalTrials.gov NCT06359301